Foundationsendocrine
The Endocrine Pancreas: Insulin, Glucagon, and the Islets
Overview
The pancreas serves two masters: its exocrine acinar cells secrete digestive enzymes into the gut, while its endocrine islets of Langerhans secrete insulin and glucagon into the blood to manage glucose. This lesson focuses on the endocrine pancreas — the beta cells that release insulin when glucose rises, the alpha cells that release glucagon when it falls, and how these antagonist hormones form the body's blood glucose control loop.
Learning objectives
- Describe the pancreas's dual exocrine and endocrine functions
- Identify islet cell types and their hormones
- Explain insulin's actions on glucose uptake and storage
- Explain glucagon's actions on the liver
- Describe insulin and glucagon as antagonist hormones
Two Glands in One Organ
The pancreas is a mixed gland with two distinct tissues. About 95% is exocrine: acinar cells produce digestive enzymes (lipase, amylase, proteases) and bicarbonate, delivered through the pancreatic duct to the small intestine. Scattered through this exocrine sea are about a million tiny endocrine clusters — the islets of Langerhans — making up just 1–2% of the organ's mass but carrying its entire blood-glucose job. The islets have no ducts; they secrete directly into a rich capillary network.
Exocrine pancreas → digestive enzymes → gut (via ducts). Endocrine pancreas (islets) → insulin/glucagon → blood (no ducts). Same organ, completely separate jobs.
Islet Cell Types
Each islet contains four main cell types. Beta cells (about 60–70% of islet cells) secrete insulin. Alpha cells (about 20%) secrete glucagon. Delta cells secrete somatostatin, which acts locally to inhibit both insulin and glucagon release — a paracrine brake. PP cells secrete pancreatic polypeptide, which modulates digestive secretion and appetite. The cells are arranged so blood flows from beta cells outward, bathing the other cells in insulin — an anatomical detail that coordinates their responses.
Beta Cells and Insulin
Beta cells are glucose sensors: when blood glucose rises after a meal, glucose enters beta cells, is metabolized, and the resulting ATP closes potassium channels, depolarizing the cell and opening calcium channels — triggering insulin release by exocytosis. Insulin then acts throughout the body: it causes muscle and fat cells to insert GLUT4 glucose transporters into their membranes (massive glucose uptake), stimulates the liver to convert glucose to glycogen, and promotes fat and protein synthesis. Insulin is the body's chief anabolic, storage-promoting hormone.
Alpha Cells and Glucagon
Alpha cells do the opposite job. When blood glucose falls — between meals, during exercise, overnight — alpha cells release glucagon, which acts primarily on the liver. Glucagon stimulates glycogenolysis (breaking stored glycogen into glucose) and gluconeogenesis (building new glucose from amino acids and glycerol), pouring glucose into the blood. Like insulin release, glucagon secretion is tuned to blood glucose itself: low glucose directly stimulates alpha cells, while high glucose and insulin suppress them.
Insulin: high glucose → released → lowers glucose, promotes storage. Glucagon: low glucose → released → raises glucose, mobilizes stores. Opposite conditions, opposite actions, one stable outcome.
Fine-Tuning the Islets
The islets also fine-tune themselves. Delta-cell somatostatin inhibits neighboring alpha and beta cells, preventing excessive swings. Incretin hormones from the gut (like GLP-1) amplify insulin release after meals — which is why oral glucose triggers more insulin than the same glucose given intravenously. And the autonomic nervous system modulates the islets: parasympathetic activity promotes insulin release during digestion, while sympathetic activity suppresses insulin and stimulates glucagon during stress — linking glucose control to the body's overall state.
The Islets in the Glucose Loop
The insulin/glucagon pair is the actuator of the blood glucose negative feedback loop (detailed in the next lesson): rising glucose → insulin → glucose falls; falling glucose → glucagon → glucose rises. When this loop works, blood glucose stays within its narrow range all day. When beta cells are destroyed (type 1 diabetes) or tissues resist insulin (type 2), the loop breaks — the subject of the diabetes physiology lesson. The endocrine pancreas is thus the hinge on which the body's entire energy economy turns.
Every cell's fuel supply depends on the islets' moment-to-moment decisions. Insulin and glucagon don't just control blood sugar — they orchestrate whether the whole body stores energy or burns it.
Key points
- The pancreas is both exocrine (digestive enzymes) and endocrine (islets of Langerhans)
- Beta cells release insulin when glucose rises; alpha cells release glucagon when glucose falls
- Insulin lowers blood glucose by driving glucose into cells and promoting storage
- Glucagon raises blood glucose via liver glycogen breakdown and gluconeogenesis
- Somatostatin from delta cells locally inhibits both insulin and glucagon
- Insulin and glucagon are antagonist hormones in a negative feedback loop
Common misconceptions
✓ Truth: The islets make at least four hormones: insulin (beta cells), glucagon (alpha cells), somatostatin (delta cells), and pancreatic polypeptide — plus the organ's entirely separate exocrine digestive function.
✓ Truth: They are released under opposite conditions: insulin when glucose is high, glucagon when glucose is low. Co-release would be a futile tug of war; the islets are wired to prevent it.
✓ Truth: Glucagon is essential in everyone: it defends against hypoglycemia between meals and overnight. Without it, blood glucose would crash every time you fasted.
Practice questions
Q1. Rising blood glucose stimulates which pancreatic cells to release their hormone?
- Alpha cells
- Beta cells
- Delta cells
- Acinar cells
Beta cells (about 60–70% of islet cells) sense rising blood glucose and secrete insulin. Alpha cells secrete glucagon; delta cells secrete somatostatin; acinar cells are exocrine.
Q2. Which best describes insulin's main actions?
- Stimulating glycogen breakdown in the liver
- Driving glucose into muscle and fat cells and promoting glycogen synthesis
- Blocking all glucose uptake
- Increasing intestinal glucose absorption
Insulin lowers blood glucose by moving GLUT4 transporters to muscle/fat cell membranes (glucose uptake), stimulating liver glycogen synthesis, and promoting fat and protein storage — an anabolic hormone.
Q3. Which hormone is released when blood glucose falls and acts to raise it?
- Insulin
- Glucagon
- Somatostatin
- Pancreatic polypeptide
Glucagon from alpha cells is insulin's antagonist: released when glucose falls, it drives hepatic glycogenolysis and gluconeogenesis to raise blood glucose back toward normal.
Click a question to reveal the answer and explanation.
Frequently asked questions
Is the pancreas an exocrine or endocrine gland?
About 95% of the pancreas is exocrine tissue (acinar cells) making digestive enzymes delivered via ducts to the small intestine. Only about 5% — the islets of Langerhans — is endocrine tissue secreting insulin and glucagon into the blood. One organ, two completely different jobs.
What do the different islet cell types secrete?
Beta cells secrete insulin when blood glucose rises; alpha cells secrete glucagon when blood glucose falls; delta cells secrete somatostatin, which locally inhibits both insulin and glucagon release. PP cells secrete pancreatic polypeptide, which modulates digestion.
What does insulin do besides lowering blood glucose?
Insulin promotes glucose uptake into muscle and fat cells (via GLUT4 transporters), stimulates glycogen synthesis in the liver, and promotes fat and protein synthesis — an anabolic, storage-promoting hormone. It also lowers blood potassium by driving K+ into cells.
How does glucagon raise blood glucose?
Glucagon raises blood glucose by stimulating glycogenolysis (breaking down liver glycogen) and gluconeogenesis (making new glucose from amino acids) in the liver. It is insulin's functional antagonist — released when glucose falls, acting when glucose is low.